BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mu W, Chu Q, Liu Y, Zhang N. A Review on Nano-Based Drug Delivery System for Cancer Chemoimmunotherapy. Nanomicro Lett 2020;12:142. [PMID: 34138136 DOI: 10.1007/s40820-020-00482-6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 12] [Article Influence: 15.5] [Reference Citation Analysis]
Number Citing Articles
1 He Y, de Araújo Júnior RF, Cruz LJ, Eich C. Functionalized Nanoparticles Targeting Tumor-Associated Macrophages as Cancer Therapy. Pharmaceutics 2021;13:1670. [PMID: 34683963 DOI: 10.3390/pharmaceutics13101670] [Reference Citation Analysis]
2 Wang Y, Luo C, Zhou S, Wang X, Zhang X, Li S, Zhang S, Wang S, Sun B, He Z, Sun J. Investigating the crucial roles of aliphatic tails in disulfide bond-linked docetaxel prodrug nanoassemblies. Asian J Pharm Sci 2021;16:643-52. [PMID: 34849169 DOI: 10.1016/j.ajps.2021.02.001] [Reference Citation Analysis]
3 Cheng G, Zong W, Guo H, Li F, Zhang X, Yu P, Ren F, Zhang X, Shi X, Gao F, Chang J, Wang S. Programmed Size-Changeable Nanotheranostic Agents for Enhanced Imaging-Guided Chemo/Photodynamic Combination Therapy and Fast Elimination. Adv Mater 2021;33:e2100398. [PMID: 33876500 DOI: 10.1002/adma.202100398] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 17.0] [Reference Citation Analysis]
4 Uddin S, Islam MR, Md Moshikur R, Wakabayashi R, Kamiya N, Moniruzzaman M, Goto M. Transdermal Delivery of Antigenic Protein Using Ionic Liquid-Based Nanocarriers for Tumor Immunotherapy. ACS Appl Bio Mater 2022. [PMID: 35472266 DOI: 10.1021/acsabm.2c00061] [Reference Citation Analysis]
5 Yixuan L, Qaria MA, Sivasamy S, Jianzhong S, Daochen Z. Curcumin production and bioavailability: A comprehensive review of curcumin extraction, synthesis, biotransformation and delivery systems. Industrial Crops and Products 2021;172:114050. [DOI: 10.1016/j.indcrop.2021.114050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Azevedo S, Costa-almeida R, Santos SG, Magalhães FD, Pinto AM. Advances in carbon nanomaterials for immunotherapy. Applied Materials Today 2022;27:101397. [DOI: 10.1016/j.apmt.2022.101397] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ding J, Guo Y. Recent Advances in Chitosan and its Derivatives in Cancer Treatment. Front Pharmacol 2022;13:888740. [DOI: 10.3389/fphar.2022.888740] [Reference Citation Analysis]
8 Bai S, Lan Y, Fu S, Cheng H, Lu Z, Liu G. Connecting Calcium-Based Nanomaterials and Cancer: From Diagnosis to Therapy. Nanomicro Lett 2022;14:145. [PMID: 35849180 DOI: 10.1007/s40820-022-00894-6] [Reference Citation Analysis]
9 Lv P, Chen X, Fu S, Ren E, Liu C, Liu X, Jiang L, Zeng Y, Wang X, Liu G. Surface engineering of oncolytic adenovirus for a combination of immune checkpoint blockade and virotherapy. Biomater Sci 2021;9:7392-401. [PMID: 34751685 DOI: 10.1039/d1bm00928a] [Reference Citation Analysis]
10 Lorenzo-Anota HY, Zarate-Triviño DG, Uribe-Echeverría JA, Ávila-Ávila A, Rangel-López JR, Martínez-Torres AC, Rodríguez-Padilla C. Chitosan-Coated Gold Nanoparticles Induce Low Cytotoxicity and Low ROS Production in Primary Leucocytes, Independent of Their Proliferative Status. Pharmaceutics 2021;13:942. [PMID: 34202522 DOI: 10.3390/pharmaceutics13070942] [Reference Citation Analysis]
11 López Mendoza CM, Alcántara Quintana LE. Smart Drug Delivery Strategies for Cancer Therapy. Front Nanotechnol 2022;3:753766. [DOI: 10.3389/fnano.2021.753766] [Reference Citation Analysis]
12 Guo H, Fan S, Liu J, Wang Y. A dual-pH sensitive drug release system for combinatorial delivery of 5‑fluorouracil and leucovorin calcium in colon cancer therapy. Inorganic Chemistry Communications 2022;141:109616. [DOI: 10.1016/j.inoche.2022.109616] [Reference Citation Analysis]
13 Baghbanbashi M, Kakkar A. Polymersomes: Soft Nanoparticles from Miktoarm Stars for Applications in Drug Delivery. Mol Pharm 2022. [PMID: 35157463 DOI: 10.1021/acs.molpharmaceut.1c00928] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Xu M, Tao J, Wei Z, Cheng Q, Yang H, Lee SM, Luo KQ, Ge W, Wang R, Zheng Y. Visualization of host-guest interactions driven bioorthogonal homing effects at the single cell level in vivo. Nano Today 2022;43:101450. [DOI: 10.1016/j.nantod.2022.101450] [Reference Citation Analysis]
15 Widjaya AS, Liu Y, Yang Y, Yin W, Liang J, Jiang Y. Tumor-permeable smart liposomes by modulating the tumor microenvironment to improve the chemotherapy. J Control Release 2022:S0168-3659(22)00094-3. [PMID: 35182612 DOI: 10.1016/j.jconrel.2022.02.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
16 Ning J, Zhang G, Balash M, Li H, Zhu L. Current Nano-Strategies to Target Tumor Microenvironment to Improve Anti-Tumor efficiency. OpenNano 2022. [DOI: 10.1016/j.onano.2022.100042] [Reference Citation Analysis]
17 Jiang D, Gao T, Liang S, Mu W, Fu S, Liu Y, Yang R, Zhang Z, Liu Y, Zhang N. Lymph Node Delivery Strategy Enables the Activation of Cytotoxic T Lymphocytes and Natural Killer Cells to Augment Cancer Immunotherapy. ACS Appl Mater Interfaces 2021;13:22213-24. [PMID: 33955746 DOI: 10.1021/acsami.1c03709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Sobierajska P, Serwotka-Suszczak A, Targonska S, Szymanski D, Marycz K, Wiglusz RJ. Synergistic Effect of Toceranib and Nanohydroxyapatite as a Drug Delivery Platform-Physicochemical Properties and In Vitro Studies on Mastocytoma Cells. Int J Mol Sci 2022;23:1944. [PMID: 35216060 DOI: 10.3390/ijms23041944] [Reference Citation Analysis]
19 Hu C, Chen J, Zhang H, Wu L, Yang P, Hou X. Nanoscale metal organic frameworks and their applications in disease diagnosis and therapy. Microchemical Journal 2022;180:107595. [DOI: 10.1016/j.microc.2022.107595] [Reference Citation Analysis]
20 Chen T, Tam N, Mao Y, Sun C, Wang Z, Hou Y, Xia W, Yu J, Wu L. A multi-hit therapeutic nanoplatform for hepatocellular carcinoma: Dual stimuli-responsive drug release, dual-modal imaging, and in situ oxygen supply to enhance synergistic therapy. Materials Today Bio 2022. [DOI: 10.1016/j.mtbio.2022.100338] [Reference Citation Analysis]
21 Darvishi F, Jahanafrooz Z, Mokhtarzadeh A. Microbial L-asparaginase as a promising enzyme for treatment of various cancers. Appl Microbiol Biotechnol. [DOI: 10.1007/s00253-022-12086-8] [Reference Citation Analysis]
22 Tian C, Tang Z, Hou Y, Mushtaq A, Naz S, Yu Z, Farheen J, Iqbal MZ, Kong X. Facile Synthesis of Multifunctional Magnetoplasmonic Au-MnO Hybrid Nanocomposites for Cancer Theranostics. Nanomaterials (Basel) 2022;12:1370. [PMID: 35458078 DOI: 10.3390/nano12081370] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Xu S, Ye C, Chen R, Li Q, Ruan J. The Landscape and Clinical Application of the Tumor Microenvironment in Gastroenteropancreatic Neuroendocrine Neoplasms. Cancers (Basel) 2022;14:2911. [PMID: 35740577 DOI: 10.3390/cancers14122911] [Reference Citation Analysis]
24 Fiekkies JTR, Fourie E, Erasmus E. Cisplatin-functionalized nanodiamonds: preparation and characterization, with potential antineoplastic application. Appl Nanosci 2021;11:2235-45. [DOI: 10.1007/s13204-021-01955-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Bariwal J, Ma H, Altenberg GA, Liang H. Nanodiscs: a versatile nanocarrier platform for cancer diagnosis and treatment. Chem Soc Rev 2022. [PMID: 35156110 DOI: 10.1039/d1cs01074c] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
26 Li Z, Wang Y, Ding Y, Repp L, Kwon GS, Hu Q. Cell‐Based Delivery Systems: Emerging Carriers for Immunotherapy. Adv Funct Mater 2021;31:2100088. [DOI: 10.1002/adfm.202100088] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 18.0] [Reference Citation Analysis]
27 Jannu AK, Puppala ER, Gawali B, Syamprasad NP, Alexander A, Marepally S, Chella N, Gangasani JK, Naidu VGM. Lithocholic acid-tryptophan conjugate (UniPR126) based mixed micelle as a nano carrier for specific delivery of niclosamide to prostate cancer via EphA2 receptor. Int J Pharm 2021;605:120819. [PMID: 34166727 DOI: 10.1016/j.ijpharm.2021.120819] [Reference Citation Analysis]
28 Singh R, Deshmukh R. Carbon nanotube as an emerging theranostic tool for oncology. Journal of Drug Delivery Science and Technology 2022;74:103586. [DOI: 10.1016/j.jddst.2022.103586] [Reference Citation Analysis]
29 Kuo Y, Rajesh R. Functionalized drug-gene delivery materials to transport inhibitor of apoptosis protein antagonists for tumor malignancy management. Journal of the Taiwan Institute of Chemical Engineers 2022;133:104283. [DOI: 10.1016/j.jtice.2022.104283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Zhang Y, Zhang W, Wang Y, Zhu J, Zhou M, Peng C, He Z, Sun J, Li Z, Gui S. Emerging nanotaxanes for cancer therapy. Biomaterials 2021;272:120790. [PMID: 33836293 DOI: 10.1016/j.biomaterials.2021.120790] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
31 Zhang C, Zhou X, Zhang H, Han X, Li B, Yang R, Zhou X. Recent Progress of Novel Nanotechnology Challenging the Multidrug Resistance of Cancer. Front Pharmacol 2022;13:776895. [DOI: 10.3389/fphar.2022.776895] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Li X, Yuan HJ, Tian XM, Tang J, Liu LF, Liu FY. Biocompatible copper sulfide-based nanocomposites for artery interventional chemo-photothermal therapy of orthotropic hepatocellular carcinoma. Mater Today Bio 2021;12:100128. [PMID: 34632360 DOI: 10.1016/j.mtbio.2021.100128] [Reference Citation Analysis]
33 Sattari S, Adeli M, Beyranvand S, Nemati M. Functionalized Graphene Platforms for Anticancer Drug Delivery. Int J Nanomedicine 2021;16:5955-80. [PMID: 34511900 DOI: 10.2147/IJN.S249712] [Reference Citation Analysis]
34 Dong X, Brahma RK, Fang C, Yao SQ. Stimulus-responsive self-assembled prodrugs in cancer therapy. Chem Sci 2022;13:4239-69. [PMID: 35509461 DOI: 10.1039/d2sc01003h] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Gupta B, Kim JO. Recent progress in cancer immunotherapy approaches based on nanoparticle delivery devices. J Pharm Investig 2021;51:399-412. [DOI: 10.1007/s40005-021-00527-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Shariatzadeh S, Moghimi N, Khalafi F, Shafiee S, Mehrabi M, Ilkhani S, Tosan F, Nakhaei P, Alizadeh A, Varma RS, Taheri M. Metallic Nanoparticles for the Modulation of Tumor Microenvironment; A New Horizon. Front Bioeng Biotechnol 2022;10:847433. [DOI: 10.3389/fbioe.2022.847433] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
37 Zhu X, Su T, Wang S, Zhou H, Shi W. New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer. Front Oncol 2022;12:834934. [PMID: 35619913 DOI: 10.3389/fonc.2022.834934] [Reference Citation Analysis]
38 Xia X, Yang X, Huang W, Xia X, Yan D. Self-Assembled Nanomicelles of Affibody-Drug Conjugate with Excellent Therapeutic Property to Cure Ovary and Breast Cancers. Nanomicro Lett 2021;14:33. [PMID: 34902075 DOI: 10.1007/s40820-021-00762-9] [Reference Citation Analysis]
39 Koksharov YA, Gubin SP, Taranov IV, Khomutov GB, Gulyaev YV. Magnetic Nanoparticles in Medicine: Progress, Problems, and Advances. J Commun Technol Electron 2022;67:101-16. [DOI: 10.1134/s1064226922020073] [Reference Citation Analysis]
40 Manisekaran R, García-Contreras R, Rasu Chettiar AD, Serrano-Díaz P, Lopez-Ayuso CA, Arenas-Arrocena MC, Hernández-Padrón G, López-Marín LM, Acosta-Torres LS. 2D Nanosheets-A New Class of Therapeutic Formulations against Cancer. Pharmaceutics 2021;13:1803. [PMID: 34834218 DOI: 10.3390/pharmaceutics13111803] [Reference Citation Analysis]
41 Sohrabi Kashani A, Packirisamy M. Cancer-Nano-Interaction: From Cellular Uptake to Mechanobiological Responses. Int J Mol Sci 2021;22:9587. [PMID: 34502495 DOI: 10.3390/ijms22179587] [Reference Citation Analysis]
42 Ye M, Gao Y, Liang M, Qiu W, Ma X, Xu J, Hu J, Xue P, Kang Y, Xu Z. Microenvironment-responsive chemotherapeutic nanogels for enhancing tumor therapy via DNA damage and glutathione consumption. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.01.086] [Reference Citation Analysis]
43 Shahrad S, Rajabi M, Javadi H, Karimi Zarchi AA, Darvishi MH. Targeting lung cancer cells with MUC1 aptamer-functionalized PLA-PEG nanocarriers. Sci Rep 2022;12:4718. [PMID: 35304550 DOI: 10.1038/s41598-022-08759-z] [Reference Citation Analysis]
44 Azevedo A, Farinha D, Geraldes C, Faneca H. Combining gene therapy with other therapeutic strategies and imaging agents for cancer theranostics. Int J Pharm 2021;606:120905. [PMID: 34293466 DOI: 10.1016/j.ijpharm.2021.120905] [Reference Citation Analysis]
45 Wang X, Zhao X, Zhong Y, Shen J, An W. Biomimetic Exosomes: A New Generation of Drug Delivery System. Front Bioeng Biotechnol 2022;10:865682. [DOI: 10.3389/fbioe.2022.865682] [Reference Citation Analysis]
46 Maharjan S, Gautam M, Poudel K, Yong CS, Ku SK, Kim JO, Byeon JH. Streamlined plug-in aerosol prototype for reconfigurable manufacture of nano-drug delivery systems. Biomaterials 2022;284:121511. [DOI: 10.1016/j.biomaterials.2022.121511] [Reference Citation Analysis]
47 Kaur D, Bharti A, Sharma T, Madhu C, Jhe W. Dielectric Properties of ZnO-Based Nanocomposites and Their Potential Applications. International Journal of Optics 2021;2021:1-20. [DOI: 10.1155/2021/9950202] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Gao T, Zhang Z, Liang S, Fu S, Mu W, Guan L, Liu Y, Chu Q, Fang Y, Liu Y, Zhang N. Reshaping Antitumor Immunity with Chemo‐Photothermal Integrated Nanoplatform to Augment Checkpoint Blockade‐Based Cancer Therapy. Adv Funct Mater 2021;31:2100437. [DOI: 10.1002/adfm.202100437] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
49 Liang Y, Li M, Yang Y, Qiao L, Xu H, Guo B. pH/Glucose Dual Responsive Metformin Release Hydrogel Dressings with Adhesion and Self-Healing via Dual-Dynamic Bonding for Athletic Diabetic Foot Wound Healing. ACS Nano 2022;16:3194-207. [PMID: 35099927 DOI: 10.1021/acsnano.1c11040] [Cited by in Crossref: 48] [Cited by in F6Publishing: 31] [Article Influence: 48.0] [Reference Citation Analysis]
50 Feng W, Huang Z, Kang X, Zhao D, Li H, Li G, Xu J, Wang X. Self-Assembled Nanosized Vehicles from Amino Acid-Based Amphiphilic Polymers with Pendent Carboxyl Groups for Efficient Drug Delivery. Biomacromolecules 2021;22:4871-82. [PMID: 34636237 DOI: 10.1021/acs.biomac.1c01164] [Reference Citation Analysis]
51 Lin X, Wang X, Gu Q, Lei D, Liu X, Yao C. Emerging nanotechnological strategies to reshape tumor microenvironment for enhanced therapeutic outcomes of cancer immunotherapy. Biomed Mater 2021. [PMID: 33601351 DOI: 10.1088/1748-605X/abe7b3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Wuhao W, Zhang Y, Lin Z, Wu X, Fan W, Chen J. Advances, challenge and prospects in cell-mediated nanodrug delivery for cancer therapy: a review. J Drug Target 2022;:1-27. [PMID: 35857432 DOI: 10.1080/1061186X.2022.2104299] [Reference Citation Analysis]
53 Kenchegowda M, Rahamathulla M, Hani U, Begum MY, Guruswamy S, Osmani RAM, Gowrav MP, Alshehri S, Ghoneim MM, Alshlowi A, Gowda DV. Smart Nanocarriers as an Emerging Platform for Cancer Therapy: A Review. Molecules 2021;27:146. [PMID: 35011376 DOI: 10.3390/molecules27010146] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
54 Wang K, Lu X, Lu Y, Wang J, Lu Q, Cao X, Yang Y, Yang Z. Nanomaterials in Animal Husbandry: Research and Prospects. Front Genet 2022;13:915911. [DOI: 10.3389/fgene.2022.915911] [Reference Citation Analysis]